StocksMedium•5 November 2026•
1 min read
Opko Health Projects 2026 Revenue Up to $278M Following LabCorp Asset Sale
Key Facts
1Opko expects FY 2026 continuing-operations revenue to range between $268 million and $278 million.
2The guidance follows a $722 million asset sale agreement with LabCorp.
Opko Health expects fiscal year 2026 revenue from continuing operations to range between $268 million and $278 million. Seeking Alpha reported that this guidance follows a $722 million agreement to sell certain assets to LabCorp.
The updated financial outlook is intended to provide clarity on the company's post-divestment operations. Shares of Opko Health saw price movement as the market assessed the new revenue targets, which reflect the company's streamlined structure following the asset sale to LabCorp.